A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)

BACKGROUND: Hydrogen sulfide (H(2)S) is a naturally occurring mediator produced by intestinal bacteria and various eukaryotic cells, which can exert protective and analgesic effects. ATB-346 is a H(2)S-releasing derivative of naproxen. In animals, ATB-346 produces negligible gastrointestinal (GI) da...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Can Assoc Gastroenterol
Main Authors: Wallace, J L, Nagy, P, Feener, T, Allain, T, Ditrói, T, Vaughan, D, Muscara, M, de Nucci, G, Buret, A
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
Oral Presentations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.002
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍